Full Length Research Paper
References
|
An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, Lim HT, Kim KJ, Ha NJ (2011). Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids in Health and Disease 2011(10):116. |
|
|
Bailey SA, Zidell RH, Perry RW (2004). Relationships between organ weight and body/brain weight in the rat: what is the best analytical endpoint? Journal of Toxicologic Pathology 32:448-466. |
|
|
Bordoni A, Amaretti A, Leonardi A, Boschetti E, Danesi F, Matteuzzi D, Roncaglia L, Raimondi S, Rossi M (2013). Cholesterol-lowering probiotics: In vitro selection and in vivo testing of bifidobacteria. Applied Microbiology and Biotechnology 9:8273-8281. |
|
|
Cha MK, Lee DO, An HM, Lee SW, Shin SH, Kwon JH, Kim KJ, Ha NJ (2012). Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Medicine 10:72. |
|
|
Chen J, Wang R, Li X-F, Wang R-L (2012). Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. British Journal of Nutrition 107:1429-1434. |
|
|
Chenoll E, Casinos B, Bataller E, Astals P, Echevarria J, Iglesias JR, Balbarie P, Ramon D, Genoves S (2011). Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Applied and Environmental Microbiology 77:1335-1343. |
|
|
Dhingra D, Lamba D, Kumar R, Gauttam S (2014). Antihyperlipidemic activity of aloe succotrina in rats: possibly mediated by inhibition of HMG-CoA reductase. ISRN Pharmacology 2014. |
|
|
Di Gioia D, Aloisio I, Mazzola G, Biavati B (2014). Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Applied Microbiology and Biotechnology 98:563-577. |
|
|
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A (2011). Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. Journal of Dairy Science 94:3288-3294. |
|
|
European Food Safety Authority (2017). EFSA Panel on Biological Hazards 2017. Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA. EFSA Journal 15(3):4664. |
|
|
FAO/WHO (2006). Probiotics in food: Health and nutritional properties and guidelines for evaluation. Report of a Joint FAO/WHO Expert Consultation. Published by FAO and WHO. pp. 1-56. |
|
|
Fijan S (2014). Microorganisms with Claimed probiotic properties: an overview of recent literature. International Journal of Environmental Research and Public Health 11:4745-4767. |
|
|
Goldin BR, Gorbach SL (1992). Probiotics for humans. In Probiotics the scientific basis, Edited by Fuller R., London: Chapman and Hall. Chapter 13:355-376. |
|
|
Greenhalgh K, Meyer KM, Aagaard KM, Wilmes P (2016). The human gut microbiome in health: establishment and resilience of microbiota over a lifetime. Environmental Microbiology 18:2103-2116. |
|
|
Guardamagna O, Amaretti A, Puddu PE, Raimondi S, Abello F, Cagliero P (2014). Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children. Nutrition 30:831-836. |
|
|
Heller KJ (2001). Probiotic bacteria in fermented foods: Product characteristics and starter organisms. The American Journal of Clinical Nutrition 73:374S-379S. |
|
|
Homayouni H, Payahoo L, Azizi A (2012). Effects of Probiotics on lipid profile: A review. American Journal of Food Technology 7:251-265. |
|
|
Isolauri E, Rautava, S, Salminen S (2012). Probiotics in the development and treatment of allergic disease. Gastroenterology Clinics of North America 41:747-762. |
|
|
Kim MJ, Lee DK, Park JE, Park IH, Seo JG, Ha NJ (2014). Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3. Biotechnology and Biotechnological Equipment 28:681-688. |
|
|
Kolovou G, Anagnostopoulou K, Cokkinos D (2005). Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgraduate Medical Journal 81:358-366. |
|
|
Kondo S, Xiao J Z, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K (2010). Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience Biotechnology and Biochemistry 74:1656-1661. |
|
|
Kumar V, Ahmed D, Anwar F, Ali M, Mujeeb M (2013). Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbellif eron-a-D-glucopyranosyl-(21 – 111)-a-D-glucopyranoside in streptozocin induced diabetic rats. SpringerPlus 2:639. |
|
|
Lee HC (2011). Liver function tests as indicators of metabolic syndrome. The Korean Journal of Hepathology 17:9-11. |
|
|
Li Y, Lv L, Ye J, Fang D, Shi D, Wu W, Wang Q, Wu J, Yang L, Bian X, Jiang X, Jiang H, Yan R, Peng C, Li L (2019). Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats. Applied Microbiology and Biotechnology 103:375-393. |
|
|
Lim SM, Kim DH (2017). Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-KB activation and lipopolysacharride production by gut microbiota. Nutrition Research 41:86-96. |
|
|
Long GG, Symanowski JT, Roback K (1998). Precision in data acquisition and reporting of organ weights in rats and mice. Journal of Toxicologic Pathology 26:316-318. |
|
|
Milani C, Lugli GA, Duranti S, Turroni F, Bottacini F, Mangifesta M (2014). Genomic encyclopedia of type strains of the genus bifidobacterium. Applied and Environmental Microbiology 80:6290-6302. |
|
|
Milani C, Turroni F, Duranti S, Lugli GA, Mancabelli L, Ferrario C, van Sinderen D, Ventura M (2016). Genomics of the genus Biï¬dobacterium reveals species-speciï¬c adaptation to the glycan-rich gut environment. Applied and Environmental Microbiology 82:980–991. |
|
|
Mohan R, Koebnick C, Schildt J, Schmidt S, Mueller M, Possner M, Radke M, Blant M (2006). Effects of Bifidobacterium lactis Bb 12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. Journal of Clinical Microbiology 44:4025-4031. |
|
|
Munoz JAM, Chenell E, Casinos B, Bataller E, Ramon D, Genoves S, Montava R, Ribes J M, Buesa J, Fabrega J, Rivero M (2011). Novel probiotic Bifidobacterium longum subsp. Infantis CECT 7210 strain active against rotavirus infections. Applied and Environmental Microbiology 77:8775-8783. |
|
|
National Academy of Sciences (2011). Guide for the care and use of laboratory animals. Eighth edition. National Academies Press. USA. |
|
|
O'Bryan CA, Pak D, Crandall PG, Lee SO, Ricke SC (2013). The role of prebiotics and probiotics in human health. Journal of Probiotics and Health 1(2):108. |
|
|
O'Callaghan A, van Sinderen D (2016). Biï¬dobacteria and their role as members of the human gut microbiota. Frontiers in Microbiology 7:925. |
|
|
Oakey HJ, Harty DW, Knox KW (1995). Enzyme production by Lactobacilli and the potential link with infective endocarditis. Journal of Applied Bacteriology 78:142-148. |
|
|
Odamaki T, Xiao JZ, Iwabuchi N, Sakamoto M, Takahashi H, Enomoto T, Benno Y (2007). Influence of Bifidobacterium longum BB 536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during pollen season. Journal of Medical Microbiology 56:1301-1308. |
|
|
Onyibe JE, Asagbra AO, Bankole AO, Elemo GN, Sanni AI (2013b). Hydrophobicity and autoaggregation of Bifidobacterium species of human and avian origin. Analytical Science Journal 1:5-16. |
|
|
Onyibe JE, Oluwole OB, Ogunbanwo ST, Sanni AI (2013a). Antibiotic susceptibility profile and survival of Bifidobacterium adolescentis and Bifidobacterium catenulatum of human and avian origin in stored yoghurt. Nigerian Food Journal 31:73-83. |
|
|
Patole SK, Rao SC, Keil AD, Nathan EA, Doherty DA, Simmer KN (2016). Benefits of Bifidobacterium breve M-16V Supplementation in preterm neonates-A retrospective cohort study. PLoSONE 11(3):e0150775. doi:10.1371/journal. pone.0150775. |
|
|
Piao Y, Liu Y, Xie X (2013). Change trends of organ weight background data in Sprague Dawley rats at different ages. Journal of Toxicologic Pathology 26:29-34. |
|
|
Salazar N, Binetti A, Gueimonde M, Alonso A, Garrido P, Gonzalez del Rey C, Gonzalez C, Ruas Madiedo P, de los Reyes-Gavilan, CG (2011). Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats. International Journal of Food Microbiology 144:342-351. |
|
|
Scheinbach S (1998). Probiotics: functionality and commercial status. Biotechnology Advances 16:581-608. |
|
|
Tsai CC, Lin PP, Hsieh YM, Zhang ZY, Wu HC, Huang CC (2014). Cholesterol-lowering potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo. The Scientific World Journal 2014. |
|
|
Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miya K, Iwatsuki K, Togashi H (2006). Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo controlled trial. Clinical Experimental Allergy 36:1425-1435. |
|
|
Yadav A, Jawal P, Jaiswal M, Kumar N, Sharma R, Shailendra R, Prasad GBKS, Bisen P (2015). Concise Review: Importance of probiotics yogurt for human health improvement. IOSR Journal of Environmental Science, Toxicology and Food Technology 9:25-30. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
